Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottl...

FDA Drug Recall #D-0257-2019 — Class III — November 2, 2018

Recall Summary

Recall Number D-0257-2019
Classification Class III — Low risk
Date Initiated November 2, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sandoz Inc
Location Princeton, NJ
Product Type Drugs
Quantity 14366 bottles

Product Description

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540

Reason for Recall

Cross Contamination with Other Products

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lots: a) JB4952, JA7322 Exp. 03/2020; b) JA7324, Exp.03/2020

Other Recalls from Sandoz Inc

Recall # Classification Product Date
D-0651-2025 Class II Cyclophosphamide Injection 500 mg/5 mL (100 mg/... Sep 5, 2025
D-0626-2025 Class II Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic ... Aug 13, 2025
D-0569-2025 Class I Cefazolin for Injection, USP, 1 gram per vial, ... Jun 27, 2025
D-0570-2025 Class I Buffered Penicillin G Potassium for Injection, ... Jun 27, 2025
D-0286-2022 Class I Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL,... Nov 17, 2021

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.